De novo cardiomyocytes from within the activated adult heart after injury
By N. Smart, S. Bollini, K. Dubé, J. Vieira, Bin Zhou, S. Davidson, D. Yellon, J. Riegler, Anthony N. Price, M. Lythgoe and 2 more. Nature, 2011
648 citations recorded by the source corpus.
A significant bottleneck in cardiovascular regenerative medicine is the identification of a viable source of stem/progenitor cells that could contribute new muscle after ischaemic heart disease and acute myocardial infarction. A therapeutic ideal—relative to cell transplantation—would be to stimulate a resident source, thus avoiding the caveats of limited graft survival, restricted homing to the site of injury and host immune rejection. Here we demonstrate in mice that the adult heart contains a resident stem or progenitor cell population, which has the potential to contribute bona fide terminally differentiated cardiomyocytes after myocardial infarction. We reveal a novel genetic label of the activated adult progenitors via re-expression of a key embryonic epicardial gene, Wilm’s tumour 1 (Wt1), through priming by thymosin β4, a peptide previously shown to restore vascular potential to adult epicardium-derived progenitor cells with injury. Cumulative evidence indicates an epicardial origin of the progenitor population, and embryonic reprogramming results in the mobilization of this population and concomitant differentiation to give rise to de novo cardiomyocytes. Cell transplantation confirmed a progenitor source and chromosome painting of labelled donor cells revealed transdifferentiation to a myocyte fate in the absence of cell fusion. Derived cardiomyocytes are shown here to structurally and functionally integrate with resident muscle; as such, stimulation of this adult progenitor pool represents a significant step towards resident-cell-based therapy in human ischaemic heart disease.
Subfields: Molecular Biology, Surgery
View Paper: https://www.semanticscholar.org/paper/bd1fc02d9aa20ba58fb41490a5995d1171946eb5
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
Citations in the corpus
- Dynamics of Cell Generation and Turnover in the Human Heart. (2015, background): “Epicardial progenitor cells were shown to be re-activated after cardiac infarction by thymosin b4, an actin monomer-binding peptide that is involved in the development of the heart and generate new cardiomyocytes (Smart et al., 2011).”